Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Spero Therapeutics Inc (SPRO)

Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Spero Therapeutics Inc 675 Massachusetts Avenue 14th Floor Cambridge MA 02139 USA

https://sperotherapeutics.com P: 857-242-1600

Description:

Spero Therapeutics Inc. is a multi-asset, clinical-stage biopharmaceutical company. It focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections. Spero Therapeutics Inc. is based in CAMBRIDGE, United States.

Key Statistics

Overview:

Market Capitalization, $K 76,528
Enterprise Value, $K 198
Shares Outstanding, K 53,893
Annual Sales, $ 103,780 K
Annual Net Income, $ 22,810 K
Last Quarter Sales, $ 73,520 K
Last Quarter Net Income, $ 51,190 K
EBIT, $ 21,480 K
EBITDA, $ 21,850 K
60-Month Beta 0.55
% of Insider Shareholders 4.52%
% of Institutional Shareholders 25.60%
Float, K 51,457
% Float 95.48%
Short Volume Ratio 0.50

Growth:

1-Year Return -16.96%
3-Year Return -89.68%
5-Year Return -87.37%
5-Year Revenue Growth 2,514.11%
5-Year Earnings Growth 119.62%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.96 on 03/13/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm 0.50
EPS Growth vs. Prev Qtr 4,700.00%
EPS Growth vs. Prev Year 74.55%
Annual Dividend Yield 0.00%
Next Ex-Dividends Date 09/16/15
Dividend Payout Ratio 0.00%

SPRO Ratios

Ratio
Price/Earnings ttm 2.87
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 38.54%
Return-on-Assets % 21.56%
Profit Margin % 21.98%
Debt/Equity 0.00
Price/Sales 0.75
Price/Cash Flow 2.71
Price/Book 0.69
Book Value/Share 2.02
Interest Coverage -1.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar